Applied Therapeutics Inc (APLT)
0.6097 -0.0187 (-2.98%) 01/23/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 0.6195 +0.0098 (-) 19:52 ET
for Thu, Jan 23rd, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Sales | 122 | 144 | 190 | -667 | 0 |
Gross Profit | 122 | 144 | 190 | -667 | N/A |
Operating Expenses | 29,865 | 20,584 | 21,283 | 20,339 | 15,495 |
Operating Income | -29,743 | -20,440 | -21,093 | -21,006 | -15,495 |
Other Income | -38,848 | 23,338 | -62,845 | -16,673 | -26,875 |
Pre-tax Income | -68,591 | 2,898 | -83,938 | -37,679 | -42,370 |
Net Income Continuous | -68,591 | 2,898 | -83,938 | -37,679 | -42,370 |
Net Income | $-68,591 | $2,898 | $-83,938 | $-37,679 | $-42,370 |
EPS Basic Total Ops | -0.48 | 0.02 | -0.67 | -0.40 | -0.47 |
EPS Basic Continuous Ops | -0.48 | 0.02 | -0.67 | -0.40 | -0.47 |
EPS Diluted Total Ops | -0.48 | -0.13 | -0.67 | -0.40 | -0.47 |
EPS Diluted Continuous Ops | -0.48 | 0.02 | -0.67 | -0.40 | -0.47 |
EPS Diluted Before Non-Recurring Items | -0.20 | -0.13 | -0.16 | -0.33 | -0.47 |
EBITDA(a) | $-29,639 | $-20,136 | $-20,589 | $-20,612 | $-14,988 |